The gold standard for treating depression is a class of medicines known as selective serotonin reuptake inhibitors (SSRIs). Recent research identified a subgroup of layer V pyramidal neurons in the cerebral cortex important for the antidepressant action of SSRIs. Using transgenic mice that have these p11-expressing neurons labeled with GFP, I characterized these neurons and their neighbours under control conditions and after chronic treatment with the SSRI fluoxetine (FLX). Experiments were conducted with a particular focus on serotonin (5-HT) responses, using whole-cell recording in acute brain slices of motor and prefrontal cortex. Further investigation explored the effects of chronic FLX treatment in a mouse model of stress. I found that...
Serotonin (5-HT) is a neurotransmitter involved in a variety of CNS functions during development and...
Major depressive episodes are the leading cause of disability worldwide. Selective serotonin reuptak...
One important target in the treatment of major depressive disorder (MDD) is the serotonin (5-hydroxy...
The gold standard for treating depression is a class of medicines known as selective serotonin reupt...
SummaryOur understanding of current treatments for depression, and the development of more specific ...
Serotonin exerts a powerful influence on neuronal excitability. In this study, we investigated the e...
International audienceLutz P.-E. Multiple serotonergic paths to antidepressant efficacy.Depression i...
Depression is a complex psychiatric disorder that is a major burden on society as 300 million people...
Antidepressants that block the serotonin transporter, (Slc6a4/SERT), selective serotonin reuptake in...
International audienceAntidepressants that block the serotonin transporter, (Slc6a4/SERT), selective...
Modelling key endophenotypes can be a powerful approach to gain insight into mechanisms underlying t...
Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are first-line antidepressants but require se...
Abstract: Fluoxetine and other serotonin-specific re-uptake inhibitors (SSRIs) are generally thought...
Abstract To test for the contribution of the 5-HT 1B receptor subtype in mediating the effects of fl...
Affective disorders represent one of the greatest global burdens of disease. Work in patients with a...
Serotonin (5-HT) is a neurotransmitter involved in a variety of CNS functions during development and...
Major depressive episodes are the leading cause of disability worldwide. Selective serotonin reuptak...
One important target in the treatment of major depressive disorder (MDD) is the serotonin (5-hydroxy...
The gold standard for treating depression is a class of medicines known as selective serotonin reupt...
SummaryOur understanding of current treatments for depression, and the development of more specific ...
Serotonin exerts a powerful influence on neuronal excitability. In this study, we investigated the e...
International audienceLutz P.-E. Multiple serotonergic paths to antidepressant efficacy.Depression i...
Depression is a complex psychiatric disorder that is a major burden on society as 300 million people...
Antidepressants that block the serotonin transporter, (Slc6a4/SERT), selective serotonin reuptake in...
International audienceAntidepressants that block the serotonin transporter, (Slc6a4/SERT), selective...
Modelling key endophenotypes can be a powerful approach to gain insight into mechanisms underlying t...
Selective serotonin (5-HT) reuptake inhibitors (SSRIs) are first-line antidepressants but require se...
Abstract: Fluoxetine and other serotonin-specific re-uptake inhibitors (SSRIs) are generally thought...
Abstract To test for the contribution of the 5-HT 1B receptor subtype in mediating the effects of fl...
Affective disorders represent one of the greatest global burdens of disease. Work in patients with a...
Serotonin (5-HT) is a neurotransmitter involved in a variety of CNS functions during development and...
Major depressive episodes are the leading cause of disability worldwide. Selective serotonin reuptak...
One important target in the treatment of major depressive disorder (MDD) is the serotonin (5-hydroxy...